Thermo Fisher Scientific Inc.

While advisory, its technical expertise and 'scoring' are essential for all tax legislation. This directly influences corporate tax rates, R&D credits, and other fiscal policies that significantly impact Thermo Fisher Scientific's financial performance and investment decisions.

This committee controls critical areas like corporate taxation (impacting TMO's profitability and investment), trade policies (tariffs affecting global supply chains), and entitlement spending (Medicare influencing demand for diagnostics and therapies).

This committee directly allocates discretionary federal spending. Its subcommittees determine precise funding for scientific research, healthcare programs, and defense initiatives, which are key revenue streams and customer bases for Thermo Fisher Scientific.

This committee directly regulates the FDA (critical for TMO's diagnostics, therapies, and pharmaceutical services) and influences the NIH (a major funder for TMO's life science research customers). It also impacts labor laws affecting TMO's workforce.

This committee oversees antitrust laws and intellectual property. Antitrust regulations directly impact Thermo Fisher Scientific's M&A strategies, while strong intellectual property protection is critical for its innovative scientific products and technologies.

Members receive classified briefings on global threats, including biological and chemical risks. This non-public information could directly influence government priorities and funding for biodefense, pandemic preparedness, and related research, creating high demand for TMO's diagnostic and research tools.